Eric Tennant, diagnosed with stage 4 bile duct cancer in 2023, faced health insurer denials for a crucial noninvasive treatment called histotripsy, despite his oncologist’s approval. The Tennant family’s struggle highlights the complicated appeals process and increasing insurance denials amid a healthcare system that often prioritizes profit over patient care.
